CompoAtlas

Women's Whey Chocolate

Natural health product licensed in Canada

If this product were sold in France

No point flagged by the rules we apply.

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the sourceMaximum per day, adult
Isolat de protéine de lactosérum

Source : Isolat de protéine de lactosérum

Potency : 90 % Whey protein

22,200 mgNot calculated
Isolat de protéine de lactosérum

Source : Isolat de protéine de lactosérum

Potency : 70 mg Calcium

Not specifiedNot calculated
Isolat de protéine de lactosérum

Source : Isolat de protéine de lactosérum

Potency : 3,347 mg Glutamic acid

Not specifiedNot calculated
Isolat de protéine de lactosérum

Source : Isolat de protéine de lactosérum

Potency : 345 mg Glycine

Not specifiedNot calculated
Isolat de protéine de lactosérum

Source : Isolat de protéine de lactosérum

Potency : 940 mg L-Alanine

Not specifiedNot calculated
Isolat de protéine de lactosérum

Source : Isolat de protéine de lactosérum

Potency : 521 mg L-Arginine

Not specifiedNot calculated
Isolat de protéine de lactosérum

Source : Isolat de protéine de lactosérum

Potency : 1,977 mg L-Aspartic acid

Not specifiedNot calculated
Isolat de protéine de lactosérum

Source : Isolat de protéine de lactosérum

Potency : 396 mg L-Cystine

Not specifiedNot calculated
Isolat de protéine de lactosérum

Source : Isolat de protéine de lactosérum

Potency : 355 mg L-Histidine

Not specifiedNot calculated
Isolat de protéine de lactosérum

Source : Isolat de protéine de lactosérum

Potency : 1,079 mg L-Isoleucine

Not specifiedNot calculated
Isolat de protéine de lactosérum

Source : Isolat de protéine de lactosérum

Potency : 2,033 mg L-Leucine

Not specifiedNot calculated
Isolat de protéine de lactosérum

Source : Isolat de protéine de lactosérum

Potency : 1,784 mg L-Lysine

Not specifiedNot calculated
Isolat de protéine de lactosérum

Source : Isolat de protéine de lactosérum

Potency : 431 mg L-Methionine

Not specifiedNot calculated
Isolat de protéine de lactosérum

Source : Isolat de protéine de lactosérum

Potency : 590 mg L-Phenylalanine

Not specifiedNot calculated
Isolat de protéine de lactosérum

Source : Isolat de protéine de lactosérum

Potency : 1,090 mg L-Proline

Not specifiedNot calculated
Isolat de protéine de lactosérum

Source : Isolat de protéine de lactosérum

Potency : 955 mg L-Serine

Not specifiedNot calculated
Isolat de protéine de lactosérum

Source : Isolat de protéine de lactosérum

Potency : 1,308 mg L-Threonine

Not specifiedNot calculated
Isolat de protéine de lactosérum

Source : Isolat de protéine de lactosérum

Potency : 315 mg Tryptophan

Not specifiedNot calculated
Isolat de protéine de lactosérum

Source : Isolat de protéine de lactosérum

Potency : 547 mg L-Tyrosine

Not specifiedNot calculated
Isolat de protéine de lactosérum

Source : Isolat de protéine de lactosérum

Potency : 1,099 mg L-Valine

Not specifiedNot calculated
Isolat de protéine de lactosérum

Source : Isolat de protéine de lactosérum

Potency : 17 mg Magnesium

Not specifiedNot calculated
Isolat de protéine de lactosérum

Source : Isolat de protéine de lactosérum

Potency : 75 mg Potassium

Not specifiedNot calculated
Acide linoléique conjugué

Source : Acide linoléique conjugué

2,500 mgNot calculated

Non-medicinal ingredients

Gomme de xanthane, Dark chocolate flavour, xylitol, Feuille de stevia rebaudiana, Cocoa Flavour, Chlorure de sodium, Saveur de chocolat

PopulationAgeQuantity per servingFrequency
AdultesNot specified1 Mesures1 Tous les jours

Uses authorised in Canada

Text supplied in English because no French text is available.

Source of (all) essential amino acids (i.e. histidine, isoleucine, leucine, lysine, methionine, phenylalanine, threonine, tryptophan, valine) for the maintenance of good health. Source of branched chain amino acids for the maintenance of good health. Source of (essential) amino acids involved in muscle protein synthesis. (Excellent) Source of protein for the maintenance of good health. (Excellent) Source of protein which helps build and repair body tissues. (Excellent) Source of proteins which helps build antibodies. Source of the minerals calcium, magnesium and phosphorus for the maintenance of good health. Source of potassium for the maintenance of good health. May help to support a modest reduction in fat mass when used with a program of reduced intake of dietary calories and increased physical activity. May help support a modest improvement to body composition when used with a program of reduced intake of dietary calories and increased physical activity.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

No French warning text available in the imported data.

Warnings are available in English on the official record.

Product record

Other names
PROTEINsmart, Wheysmart, Women's Whey, Women's Whey with CLA Chocolate Powder
Licence holder
Jamieson Laboratories Ltd./ Nutricorp International
NPN or DIN-HM
80054110
Status
Active licence
Licence date
19 September 2014
Revision date
8 September 2026
Form
Poudre
Route of administration
Orale
Application type
Non traditionnelle

Source

Official Health Canada record, licence 80054110

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

Official warnings (Health Canada)

Health Canada publishes warnings on these ingredients:

  • Acide linoléique conjugué
    Read the warning, when it applies and the studies cited

    CONJUGATED LINOLEIC ACID

    Route of administration: Oral

    Cautions and warnings

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are breastfeeding.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are obese or have cardiovascular disease (CVD) risk factors (Tholstrup et al. 2008; Gaullier et al. 2007; Steck et al. 2007; Larsen et al. 2006; Taylor et al. 2006; Gaullier et al. 2005; Smedman et al. 2005; Gaullier et al. 2004; Basu et al. 2000a,b).

    Sources cited by Health Canada (9)
    • Basu S, Risérus U, Turpeinen A, Vessby B. 2000a. Conjugated linoleic acid induces lipid peroxidation in men with abdominal obesity. Clinical Science 99(6):511-516.
    • Gaullier JM, Halse J, Høivik HO, Høye K, Syvertsen C, Nurminiemi M, Hassfeld C, Einerhand A, O'Shea M, Gudmundsen O. 2007. Six months supplementation with conjugated linoleic acid induces regional-specific fat mass decreases in overweight and obese. British Journal of Nutrition 97(3):550-560.
    • Gaullier JM, Halse J, Hoye K, Kristiansen K, Fagertun H, Vik H, Gudmundsen O. 2004. Conjugated linoleic acid supplementation for 1 y reduces body fat mass in healthy overweight humans. The American Journal of Clinical Nutrition 79:1118-1125.
    • Gaullier JM, Halse J, Hoye K, Kristiansen K, Fagertun H, Vik H, Gudmundsen O. 2005. Supplementation with conjugated linoleic acid for 24 months is well tolerated by and reduces body fat mass in healthy, overweight humans. The Journal of Nutrition 135(4):778-784.
    • Larsen TM, Toubro S, Gundmensen O, Astrup A. 2006. Conjugated linoleic acid supplementation for 1 y does not prevent weight or body fat gain. The American Journal of Clinical Nutrition 83(3):606-612.
    • Smedman A, Basu S, Jovinge S, Fredrikson GN, Vessby B. 2005. Conjugated linoleic acid increased C-reactive protein in human subjects. British Journal of Nutrition 94(5):791-795.
    • Steck SE, Chalecki AM, Miller P, Conway J, Austin GL, Hardin JW, Albright CD, Thuillier P. 2007. Conjugated linoleic acid supplementation for twelve weeks increases lean body mass in obese humans. The Journal of Nutrition 137(5):1188-1193.
    • Taylor JS, Williams SR, Rhys R, James P, Frenneaux MP. 2006. Conjugated linoleic acid impairs endothelial function. Arteriosclerosis, Thrombosis, and Vascular Biology 26(2):307-312.
    • Tholstrup T, Raff M, Straarup EM, Lund P, Basu S, Bruun JM. 2008. An oil mixture with trans-10, cis-12 conjugated linoleic acid increases markers of inflammation and in vivo lipid peroxidation compared with cis-9, trans-11 conjugated linoleic acid in postmenopausal women. The Journal of Nutrition 138(8):1445-1451.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if your goal is to achieve weight loss.

    Contraindications

    Do not use if you are pregnant (HC 2010).

    Sources cited by Health Canada (2)
    • HC 2010: Health Canada: Prenatal Nutrition Guidelines for health Professionals: Gestational weight gain [Accessed 2024 April 7]. Available from: https://www.canada.ca/content/dam/hc-sc/migration/hc-sc/fn-an/alt_formats/pdf/nutrition/prenatal/ewba-mbsa-eng.pdf
    • SC 2010 : Santé Canada : Lignes directrices sur la nutrition pendant la grossesse à l'intention des professionnels de la santé : Gain de poids pendant la grossesse. [Consulté le 7 avril 2024]. Disponible à : https://www.canada.ca/content/dam/hc-sc/migration/hc-sc/fn-an/alt_formats/pdf/nutrition/prenatal/ewba-mbsa-fra.pdf

    Do not use if you have cardiovascular disease (CVD), diabetes, metabolic syndrome or insulin resistance (Tholstrup et al. 2008; Gaullier et al. 2007; Steck et al. 2007; Larsen et al. 2006; Taylor et al. 2006; Gaullier et al. 2005; Smedman et al. 2005; Gaullier et al. 2004; Moloney et al. 2004; Basu et al. 2000a,b).

    Sources cited by Health Canada (10)
    • Basu S, Risérus U, Turpeinen A, Vessby B. 2000a. Conjugated linoleic acid induces lipid peroxidation in men with abdominal obesity. Clinical Science 99(6):511-516.
    • Gaullier JM, Halse J, Høivik HO, Høye K, Syvertsen C, Nurminiemi M, Hassfeld C, Einerhand A, O'Shea M, Gudmundsen O. 2007. Six months supplementation with conjugated linoleic acid induces regional-specific fat mass decreases in overweight and obese. British Journal of Nutrition 97(3):550-560.
    • Gaullier JM, Halse J, Hoye K, Kristiansen K, Fagertun H, Vik H, Gudmundsen O. 2004. Conjugated linoleic acid supplementation for 1 y reduces body fat mass in healthy overweight humans. The American Journal of Clinical Nutrition 79:1118-1125.
    • Gaullier JM, Halse J, Hoye K, Kristiansen K, Fagertun H, Vik H, Gudmundsen O. 2005. Supplementation with conjugated linoleic acid for 24 months is well tolerated by and reduces body fat mass in healthy, overweight humans. The Journal of Nutrition 135(4):778-784.
    • Larsen TM, Toubro S, Gundmensen O, Astrup A. 2006. Conjugated linoleic acid supplementation for 1 y does not prevent weight or body fat gain. The American Journal of Clinical Nutrition 83(3):606-612.
    • Moloney F, Yeow TP, Mullen A, Nolan JJ, Roche HM. 2004. Conjugated linoleic acid supplementation, insulin sensitivity, and lipoprotein metabolism in patients with type 2 diabetes mellitus. The American Journal of Clinical Nutrition 80(4):887-895.
    • Smedman A, Basu S, Jovinge S, Fredrikson GN, Vessby B. 2005. Conjugated linoleic acid increased C-reactive protein in human subjects. British Journal of Nutrition 94(5):791-795.
    • Steck SE, Chalecki AM, Miller P, Conway J, Austin GL, Hardin JW, Albright CD, Thuillier P. 2007. Conjugated linoleic acid supplementation for twelve weeks increases lean body mass in obese humans. The Journal of Nutrition 137(5):1188-1193.
    • Taylor JS, Williams SR, Rhys R, James P, Frenneaux MP. 2006. Conjugated linoleic acid impairs endothelial function. Arteriosclerosis, Thrombosis, and Vascular Biology 26(2):307-312.
    • Tholstrup T, Raff M, Straarup EM, Lund P, Basu S, Bruun JM. 2008. An oil mixture with trans-10, cis-12 conjugated linoleic acid increases markers of inflammation and in vivo lipid peroxidation compared with cis-9, trans-11 conjugated linoleic acid in postmenopausal women. The Journal of Nutrition 138(8):1445-1451.

    Known adverse reactions

    When using this product you may experience gastrointestinal discomfort/disturbances (Gaullier et al. 2007; Pinkoski et al. 2006; Berven et al. 2000; Blankson et al. 2000).

    Sources cited by Health Canada (4)
    • Berven G, Bye A, Hals O, Blankson H, Fagertun H, Thom E, Wadstein J, Gudmundsen O. 2000. Safety of conjugated linoleic acid (CLA) in overweight and obese human volunteers. European Journal of Lipid Science and Technology 102(7):455-462.
    • Blankson H, Stakkestad JA, Fagertun H, Thom E, Wadstein J, Gudmundsen O. 2000. Conjugated linoleic acid reduces body fat mass in overweight and obese humans. The Journal of Nutrition 130(12):2943-2948.
    • Gaullier JM, Halse J, Høivik HO, Høye K, Syvertsen C, Nurminiemi M, Hassfeld C, Einerhand A, O'Shea M, Gudmundsen O. 2007. Six months supplementation with conjugated linoleic acid induces regional-specific fat mass decreases in overweight and obese. British Journal of Nutrition 97(3):550-560.
    • Pinkoski C, Chilibeck PD, Candow DG, Esliger D, Ewaschuk JB, Facci M, Farthing JP, Zello GA. 2006. The effects of conjugated linoleic acid supplementation during resistance training. Medicine and Science in Sports and Exercise 38(2):339-348.

    Health Canada monograph dated 10 January 2025

They concern the ingredient, not this product or its dose. They do not replace medical advice.

List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).

Has the product changed? Photograph the packaging.

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

Cite this page: CompoAtlas, “Women's Whey Chocolate”, https://compoatlas.com/en/supplements/canada/80054110-women-s-whey-chocolate, updated 8 September 2026.

Enter to analyse, Shift+Enter for a new line